Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan
et al
Ann Rheum Dis
.
2022 Aug;81(8):e149.
doi: 10.1136/annrheumdis-2020-218441.
Epub 2020 Jul 24.
Authors
Jixin Zhong
1
,
Lingli Dong
1
Affiliation
1
Department of Rheumatology and Immunlogy, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China zhongjixin620@163.com tjhdongll@163.com.
PMID:
32709678
DOI:
10.1136/annrheumdis-2020-218441
No abstract available
Keywords:
antirheumatic agents; immune system diseases; therapeutics.
Publication types
Research Support, Non-U.S. Gov't
Letter
Comment
MeSH terms
COVID-19*
Humans
Malaysia / epidemiology
Rheumatic Diseases* / complications